ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Imatinib is an efficacious drug against chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST) due to selective inhibition of c-KIT and BCR-ABL kinases.